Schedule 4. 5(d) identifies each individual item of Debt of the Company and/or any Company Subsidiary currently outstanding in excess of $25,000 as of the date hereof.
Appears in 6 contracts
Samples: Securities Purchase Agreement (Integrated Biopharma Inc), Securities Purchase Agreement (Integrated Biopharma Inc), Securities Purchase Agreement (Integrated Biopharma Inc)